Abstract:NYGGF4 is a recently identified gene that is involved in obesity-associated insulin resistance. Previous data from this laboratory have demonstrated that NYGGF4 overexpression might contribute to the development of insulin resistance (IR) and to mitochondrial dysfunction. Additionally, NYGGF4 knockdown enhanced insulin sensitivity and mitochondrial function in 3T3-L1 adipocytes. We designed this study to determine whether silencing of NYGGF4 in 3T3-L1 adipocytes could rescue the effect of insulin sensitivity and mitochondrial function induced by the cyanide p-trifluoromethoxyphenyl-hydrazone (FCCP), a mitochondrion uncoupler, to ascertain further the mechanism of NYGGF4 involvement in obesity-associated insulin resistance. We found that 3T3-L1 adipocytes, incubated with 5μM FCCP for 12h, had decreased levels of insulin-stimulated glucose uptake and had impaired insulin-stimulated GLUT4 translocation. Silencing also diminished insulin-stimulated tyrosinephosphorylation of IRS-1 and serine phosphorylation of Akt. This phenomenon contrasts with the effect of NYGGF4 knockdown on insulin sensitivity and describes the regulatory function of NYGGF4 in adipocytes insulin sensitivity. We next analyzed the mitochondrial function in NYGGF4-silenced adipocytes incubated with FCCP. NYGGF4 knockdown partly rescued the dissipation of mitochondrial mass, mitochondrial DNA, intracellular ATP synthesis, and intracellular reactive oxygen species (ROS) production occurred following the addition of FCCP, as well as inhibition of mitochondrial transmembrane potential (ΔΨm) in 3T3-L1 adipocytes incubated with FCCP. Collectively, our results suggested that addition of silencing NYGGF4 partly rescued the effect of insulin resistance and mitochondrial dysfunction in NYGGF4 silenced 3T3-L1 adipocytes incubated with FCCP, which might explain the involvement of NYGGF4-induced IR and the development of NYGGF4 in mitochondrial function.

Overexpression of TFAM Protects 3T3-L1 Adipocytes from NYGGF4 (PID1) Overexpression-Induced Insulin Resistance and Mitochondrial Dysfunction

Overexpression of Nyggf4 (pid1) Induces Mitochondrial Impairment in 3T3-L1 Adipocytes

Nyggf4 (pid1) Effects on Insulin Resistance Are Reversed by Metformin in 3T3-L1 Adipocytes

Effects of NYGGF4 knockdown on insulin sensitivity and mitochondrial function in 3T3-L1 adipocytes

Knockdown of Nyggf4 (pid1) Rescues Insulin Resistance and Mitochondrial Dysfunction Induced by Fccp in 3T3-L1 Adipocytes

Over-expression of NYGGF4 Inhibits Glucose Transport in 3T3-L1 Adipocytes Via Attenuated Phosphorylation of IRS-1 and Akt

Influence of NYGGF4 (PID1) Gene Over-Expression on Mitochondrial Metabolism in Adipocytes

Α-Lipoic Acid Protects 3T3-L1 Adipocytes from NYGGF4 (PID1) Overexpression-Induced Insulin Resistance Through Increasing Phosphorylation of IRS-1 and Akt

Theaflavin 3,3′‐digallate Reverses the Downregulation of Connexin 43 and Autophagy Induced by High Glucose Via AMPK Activation in Cardiomyocytes

[Effects of NYGGF4 Gene Over-Expression on the Insulin Sensitivity and Secretory Function of Adipocytes].

Effect of NYGGF4 Gene Silencing on Mitochondrial Metabolism in 3T3 - L1 Adipocytes

Influence of Over-Expression of NYGGF4 Gene on Mitochondrial Morphology and Dynamics in Adipocytes

Roles of Uncoupling Proteins in Insulin Resistance Induced by NYGGF4 Gene in Adipocytes

NYGGF4 As a New Therapeutic Target for Obesity-Associated Insulin Resistance

Over-expression of NYGGF4 (PID1) inhibits glucose transport in skeletal myotubes by blocking the IRS1/PI3K/AKT insulin pathway

Mitochondrial Dysfunction is Induced by the Overexpression of Ucp4 in 3T3-L1 Adipocytes

Genomic Dna Methylation Changes in Nyggf4-Overexpression 3T3-L1 Adipocytes

NYGGF4 homologous gene expression in 3T3-L1 adipocytes: regulation by FFA and adipokines

Mitochondrial Dysfunction is Induced by High Levels of Glucose and Free Fatty Acids in 3T3-L1 Adipocytes.

Omega-3 Polyunsaturated Fatty Acids Promote SNAREs Mediated GLUT4 Vesicle Docking and Fusion

Fam3a Enhances Adipogenesis of 3T3-L1 Preadipocytes Via Activation of Atp-P2 Receptor-Akt Signaling Pathway